Insider Transactions in Q1 2021 at Apollo Endosurgery, Inc. (APEN)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2021
|
John J Molesphini EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
14,028
+15.69%
|
-
|
|
Mar 10
2021
|
Bret Schwartzhoff VP, US Sales & Marketing |
BUY
Grant, award, or other acquisition
|
Direct |
14,028
+12.0%
|
-
|
|
Mar 10
2021
|
Chas Mc Khann President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
707,278
+50.0%
|
-
|
|
Mar 10
2021
|
Christopher J. Gostout Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,020
+11.47%
|
-
|
|
Mar 10
2021
|
John R Barr Director |
BUY
Open market or private purchase
|
Direct |
10,000
+5.97%
|
$50,000
$5.88 P/Share
|
|
Mar 10
2021
|
Stefanie L. Cavanaugh CFO, Treasurer, Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
14,028
+12.76%
|
-
|
|
Feb 24
2021
|
Sciences Ii L P Ptv > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,972,805
-87.5%
|
-
|
|
Feb 24
2021
|
Sciences Ii L P Ptv > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
19,528
+50.0%
|
-
|
|
Feb 24
2021
|
Matthew S Crawford > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
6,461
+2.36%
|
-
|
|
Feb 24
2021
|
Matthew S Crawford > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,972,805
-87.5%
|
-
|
|
Feb 24
2021
|
Matthew S Crawford > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
19,528
+50.0%
|
-
|
|
Feb 23
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,166
+13.61%
|
$16,664
$4.62 P/Share
|
|
Feb 23
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,055
+1.96%
|
$32,220
$4.62 P/Share
|
|
Feb 22
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,103
+2.5%
|
$40,412
$4.8 P/Share
|
|
Feb 18
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,649
+0.43%
|
$6,596
$4.75 P/Share
|
|
Feb 18
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
378
+1.67%
|
$1,512
$4.75 P/Share
|
|
Feb 05
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
22,589
+18.12%
|
$90,356
$4.99 P/Share
|
|
Feb 05
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
30,954
+7.49%
|
$123,816
$4.71 P/Share
|
|
Feb 04
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
9,729
+8.8%
|
$38,916
$4.71 P/Share
|
|
Feb 03
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
28,388
+12.31%
|
$113,552
$4.48 P/Share
|
|
Feb 02
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,873
+14.74%
|
$43,492
$4.42 P/Share
|
|
Feb 01
2021
|
Neil Gagnon > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
473
+0.13%
|
$1,892
$4.2 P/Share
|
|
Jan 06
2021
|
Stefanie L. Cavanaugh CFO, Treasurer, Secretary |
BUY
Other acquisition or disposition
|
Direct |
218
+0.27%
|
-
|
|
Jan 05
2021
|
Todd Newton Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
3,479
+0.84%
|
-
|